Tandem Diabetes Care, Inc. Increase (Decrease) in Contract with Customer, Liability
Tandem Diabetes Care, Inc. (TNDM) reported Increase (Decrease) in Contract with Customer, Liability of -$3.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-06
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$2.70M.
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$1.08M.
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$686.00K.
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$1.39M.
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$4.79M.
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$34.74M, a 261.38% decline from fiscal 2023.
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $21.52M, a 157.54% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was $8.36M, a 21.23% decline from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.78M 10-Q · filed 2026-08-06 | -$4.47M derived: sum of 3 quarters · filed 2026-08-06 | -$5.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.08M 10-Q · filed 2026-05-07 | -$1.76M derived: sum of 2 quarters · filed 2026-05-07 | -$3.16M derived: sum of 3 quarters · filed 2026-05-07 | -$4.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$686.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.08M derived: sum of 2 quarters · filed 2026-02-19 | -$3.19M derived: sum of 3 quarters · filed 2026-08-06 | -$4.79M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.51M derived: sum of 2 quarters · filed 2026-08-06 | -$4.10M 10-Q · filed 2025-11-06 | -$35.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.71M 10-Q · filed 2026-08-06 | -$33.86M derived: sum of 3 quarters · filed 2026-08-06 | -$36.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-07 | -$32.74M derived: sum of 2 quarters · filed 2026-05-07 | -$35.07M derived: sum of 3 quarters · filed 2026-05-07 | -$35.96M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$31.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$33.48M derived: sum of 2 quarters · filed 2026-02-19 | -$34.36M derived: sum of 3 quarters · filed 2026-02-19 | -$34.74M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.22M derived: sum of 2 quarters · filed 2025-11-06 | -$3.59M 10-Q · filed 2025-11-06 | $7.89M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$889.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.26M 10-Q · filed 2025-08-06 | $10.22M derived: sum of 3 quarters · filed 2026-02-19 | $17.32M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$372.00K 10-Q · filed 2025-04-30 | $11.11M derived: sum of 2 quarters · filed 2026-02-19 | $18.21M derived: sum of 3 quarters · filed 2026-02-19 | $20.23M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $11.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $18.58M derived: sum of 2 quarters · filed 2026-02-19 | $20.60M derived: sum of 3 quarters · filed 2026-02-19 | $21.52M 10-K · filed 2026-02-19 |
| 2023-09-30 | $7.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $9.12M derived: sum of 2 quarters · filed 2024-11-06 | $10.04M 10-Q · filed 2024-11-06 | $13.40M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.95M 10-Q · filed 2024-08-01 | $6.31M derived: sum of 3 quarters · filed 2025-02-26 | $8.37M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $925.00K 10-Q · filed 2024-05-02 | $4.29M derived: sum of 2 quarters · filed 2025-02-26 | $6.35M derived: sum of 3 quarters · filed 2025-02-26 | $7.99M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $5.42M derived: sum of 2 quarters · filed 2025-02-26 | $7.07M derived: sum of 3 quarters · filed 2025-02-26 | $8.36M 10-K · filed 2025-02-26 |
| 2022-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $3.71M derived: sum of 2 quarters · filed 2023-11-01 | $5.00M 10-Q · filed 2023-11-01 | $7.83M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.93M 10-Q · filed 2023-08-03 | $5.77M derived: sum of 3 quarters · filed 2024-02-21 | $8.26M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $1.29M 10-Q · filed 2023-05-03 | $4.13M derived: sum of 2 quarters · filed 2024-02-21 | $6.61M derived: sum of 3 quarters · filed 2024-02-21 | $10.03M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $5.32M derived: sum of 2 quarters · filed 2024-02-21 | $8.74M derived: sum of 3 quarters · filed 2024-02-21 | $10.61M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $5.90M derived: sum of 2 quarters · filed 2022-11-02 | $7.77M 10-Q · filed 2022-11-02 | $10.59M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $5.29M 10-Q · filed 2022-08-03 | $8.10M derived: sum of 3 quarters · filed 2023-02-22 | $9.65M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $1.87M 10-Q · filed 2022-05-04 | $4.68M derived: sum of 2 quarters · filed 2023-02-22 | $6.23M derived: sum of 3 quarters · filed 2023-02-22 | $7.38M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $4.36M derived: sum of 2 quarters · filed 2023-02-22 | $5.50M derived: sum of 3 quarters · filed 2023-02-22 | $7.03M 10-K · filed 2023-02-22 |
| 2020-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.69M derived: sum of 2 quarters · filed 2021-11-03 | $4.21M 10-Q · filed 2021-11-03 | $5.22M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.67M 10-Q · filed 2021-08-04 | $3.67M derived: sum of 3 quarters · filed 2022-02-22 | $4.72M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $1.52M 10-Q · filed 2021-05-05 | $2.53M derived: sum of 2 quarters · filed 2022-02-22 | $3.57M derived: sum of 3 quarters · filed 2022-02-22 | $5.25M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.05M derived: sum of 2 quarters · filed 2022-02-22 | $3.73M derived: sum of 3 quarters · filed 2022-02-22 | $4.59M 10-K · filed 2022-02-22 |
| 2019-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.73M derived: sum of 2 quarters · filed 2020-11-05 | $3.59M 10-Q · filed 2020-11-05 | $4.48M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.54M 10-Q · filed 2020-07-30 | $3.44M derived: sum of 3 quarters · filed 2021-02-24 | $4.17M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $861.00K 10-Q · filed 2020-04-30 | $1.76M derived: sum of 2 quarters · filed 2021-02-24 | $2.50M derived: sum of 3 quarters · filed 2021-02-24 | $2.59M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $896.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.64M derived: sum of 2 quarters · filed 2021-02-24 | $1.73M derived: sum of 3 quarters · filed 2021-02-24 | $2.07M 10-K · filed 2021-02-24 |
| 2018-09-30 | $739.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $829.00K derived: sum of 2 quarters · filed 2019-11-04 | $1.18M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $439.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $349.00K 10-Q · filed 2019-04-30 | |||
| 2017-12-31 | -$3.91M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $4.61M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |